相关实验视频
Updated: Jul 16, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
针对侵袭性膀癌的免疫治疗策略:综合性综述
Yingying Wang1, Min He1, Jian Li1
1Department of Pharmacy, The First People's Hospital of Xiaoshan District, Hangzhou, China.
Frontiers in immunology
|May 15, 2025
概括
膀癌免疫疗法,包括PD-1抑制剂和组合疗法,提供了更好的结果和膀保护选择. 本综述分析了针对侵袭性膀癌的当前和未来免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 膀癌,特别是肌肉侵入性膀癌 (MIBC),对治疗提出了重大挑战.
- 标准治疗方法,如激进囊切除术 (RC) 和新辅助化疗,具有风险并影响生活质量.
- 膀保护疗法 (BPT) 和免疫疗法正在获得突出地位.
研究的目的:
- 提供当前针对侵袭性膀癌的免疫治疗策略的全面分析.
- 突出这些治疗方法的临床应用和未来潜力.
- 讨论免疫治疗在非肌肉侵入性和肌肉侵入性膀癌中的作用.
主要方法:
- 目前关于膀癌免疫治疗的文献综述.
- 分析治疗策略,包括Bacillus Calmette-Guérin (BCG),免疫检查点抑制剂 (PD-1/PD-L1) 和组合疗法.
- 在非肌肉侵入性膀癌 (NMIBC) 和MIBC.临床应用和结果的评估.
主要成果:
- PD-1 抑制剂在BCG不响应的NMIBC中表现有前途.
- 新辅助免疫疗法改善了MIBC的病理完整反应 (pCR),有助于膀的保存.
- 与放射治疗和化疗相结合的疗法通过免疫细胞死亡等机制提高了疗效.
结论:
- 免疫疗法彻底改变了膀癌症的治疗方法.
- 目前的策略提供了更好的疗效和膀保存的可能性.
- 未来的研究方向和免疫治疗方法的潜力需要进一步研究.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
01:30Cancer Vaccines
307
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
307